Eli Lilly and Company (LLY) closed October 9, 2026 at $1,169.85 per share, a decline of 1.55% over the prior 24 hours. The daily pullback trimmed but did not erase recent momentum for the pharmaceutical giant.
Looking at a broader window, the stock has gained 1.72% over the past seven days and 4.09% over the past 30 days, suggesting the single-session dip represents a modest pause within an otherwise upward trend.
Eli Lilly's market capitalization stood at $1,059.57 billion as of the close, keeping the company among the largest by total market value in the United States equity market.
The combination of a slight daily retreat and positive medium-term performance reflects the mixed signals that can emerge in large-cap pharmaceutical trading, where short-term price swings often occur against a backdrop of longer-term movement.
